Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

PURPOSE: Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer cells in vitro and tumors in vivo. However, there is little clinical data to support this. Our purpose was to determine whether metform...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jiralerspong, Sao, Palla, Shana L., Giordano, Sharon H., Meric-Bernstam, Funda, Liedtke, Cornelia, Barnett, Chad M., Hsu, Limin, Hung, Mien-Chie, Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2009
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736070/
https://ncbi.nlm.nih.gov/pubmed/19487376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.19.6410
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller